|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
21 March 2022 |
|
Main ID: |
NCT00768820 |
|
Date of registration:
|
07/10/2008 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
VCFS |
|
Scientific title:
|
The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors |
|
Date of first enrolment:
|
May 2001 |
|
Target sample size:
|
400 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT00768820 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
|
|
Phase:
|
Phase 4
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Contacts
|
|
Name:
|
Doron Gothelf, MD |
|
Address:
|
|
|
Telephone:
|
972-03-5302663 |
|
Email:
|
gothelf@post.tau.ac.il |
|
Affiliation:
|
|
|
|
Name:
|
Doron Gothelf, MD |
|
Address:
|
|
|
Telephone:
|
972-03-5302663 |
|
Email:
|
|
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- chromosomal deletion proven by FISH examination
Exclusion Criteria:
Age minimum:
N/A
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Fragile X Syndrome
|
|
Williams Syndrome
|
|
Velocardiofacial Syndrome
|
|
Intervention(s)
|
|
Drug: methylphenidate, fluoxetin, risperidone
|
|
Primary Outcome(s)
|
|
Measure that are used: psychological measures, molecular tests, responsiveness to medical treatments
[Time Frame: 2 years]
|
|
Secondary ID(s)
|
|
SCMCI082455CTIL
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|